A review on lung cancer

  • T. Jyothi B. Pharmacy, IV Year, Ratnam Institute of Pharmacy, Pidathapolur (V & P), Muthukur (M), SPSR Nellore District-524 346, Andhra Pradesh.
  • M. Sowjanya Assistant professor, Department of Pharmacy practice , Ratnam Institute of Pharmacy, Pidathapolur (V & P), Muthukur (M), SPSR Nellore District-524 346, Andhra Pradesh.
  • Yerikala Ramesh Professor, Department of Pharmaceutics, Ratnam Institute of Pharmacy, Pidathapolur (V & P), Muthukur (M), SPSR Nellore District-524 346, Andhra Pradesh.
  • Y. Prapurna Chandra Principal and Professor, Department of Pharmacology, Ratnam Institute of Pharmacy, Pidathapolur (V & P), Muthukur (M), SPSR Nellore District-524 346, Andhra Pradesh.
  • Venugopalaiah Penabaka Professor & HOD, Department of Pharmaceutics, Ratnam Institute of Pharmacy, Pidathapolur (V & P), Muthukur (M), SPSR Nellore District-524 346, Andhra Pradesh.

Abstract

Lung cancer is a kind of cancer that starts as a growth of cells in the lungs. The lungs are two spongy organs in the chest that control breathing. People who smoke have the greatest risk of lung cancer. The risk of lung cancer increases with the length of time and number of cigarettes smoked. Quitting smoking, even after smoking for many years, significantly lowers the chances of developing lung cancer. Lung cancer also can happen in people who have never smoked. Lung cancer is the prime cause of cancer death among both men and women according to WHO report 2.09 million cases globally. It is also the chief cause of cancer death among men and the second leading cause of cancer death among women worldwide. The lung cancer classified into two different types is small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). This article focuses on modifiable risk factors, including tobacco smoking, occupational carcinogens, diet, and ionizing radiation. It also discusses briefly the molecular and genetic aspects of lung carcinogenesis. Lung cancer is the most frequent cancer type with high mortality and morbidity rate worldwide. Studies have chemotherapy. own that smoking, environmental factors including occupational exposure, radon exposure, air pollution, radiation, obesity, diet and hereditary susceptibility are related to developing risk of LC.

Keywords: Lung cancer, lifestyle, risk factors, aetiology, patophysiology

References

1. What Is Cancer? - NCI.http://www.cancer.gov/about-cancer/understanding/what-is-cancer
2.V. Sankar, R. Kothai. Lung cancer , International journal of health sciences and Research. Vol:13; Issue:10; October 2023.
3. Cagnur Elpen Kodaz. Lung Cancer Risk factors. Eurasian journal of medical advances. 2022;2(4):159–162.
4. V. Sankar, R. Kothai, N. Vanisri1, Akilandeswari. S1, G. Anandharaj. Lung Cancer. International Journal of Health Sciences and Research.2023; Vol.13; Issue: 10.
5. Faraz Siddiqui; Sarosh Vaqar; Abdul H. Siddiqui. Lung Cancer.2023.
6. Madhava Reddy P V, Guduru Rajeswari, Satrasala Neelima, & Arava Vidyadhari. Cancer Immunotherapy: Theory and it’s Application. , Future J. Pharm. Health. Sci, 2022, 2(4), 256–268.
7. Faraz Siddiqui; Sarosh Vaqar; Abdul H. Siddiqui. Lung Cancer.2023.
8. Cecilia Zappa, shaker A. Mousa. Non-small cell lung cancer: current treatment and future advances. Translational lung cancer research. Journal focusing on closing the gap between “bench and depside”, Vol:5, No:3 (June 30,2016).
9. Lynne Eldrige, MD how non-small cell lung cancer is treated . Updated on October 13, 2024 https://www.verywellhealth.com/cancer-overview-4581995.
10. Squamous Cell Carcinoma in the Lungs: What to Know By Lynne Eldridge, MD Updated on October 11, 2024 Medically reviewed by Doru Paul, MD
11. lung adenocarcinoma dogodan therapeutics, inc http://www.dogodon.com/home/luad
12. https://my.clevelandclinic.org/
13.Charles M. Rudin, Elisabeth Brambilla, Corinne Faivre-Finn & Julien Sage Small-cell lung cancer Nature Reviews Disease Primers volume 7, Article number: 3 (2021)
14. Charles S. Dela Cruz. Clin chest Med, Lung cancer; Epidemiology, Etiology and Prevention, National Library of Medicine; 3 November 2011.
15. Aishwarya Anand, Sowmya M, & Kamiel S. A Review on Drug-Drug Interactions Between Cancer Drugs. Int. J. of Clin. Pharm. Med. Sci, 2021, 1(3), 73–80.
16.https://indonesianrecipes.com/download/openpicture.php?img=https://i0.wp.com/post.healthline.com/wp-content/uploads/2021/12/1796042-MR-CLONE-Early-Signs-of-Lung-Cancer-1297x2788-body-1296x2375.png?w=1155&h=4995of small cell lung cancer
17. https://Searchapi.cancer.org.
18. Austin J. Sim , Evangelia Kaza , Lisa Singer , Stephen A. Rosenberg A review of the role of MRI in diagnosis and treatment of early-stage lung cancer vol 24, sep 2020, pages 16-22.
19. Stefan Hammerschmidt, Hubert Wirtz Lung Cancer: Current Diagnosis and Treatment 106(49): 809–20, 2009.
20. Lung cancer - Diagnosis and treatment - Mayo Clinic
21. Cecilia zappa, shaker A. Mousa. Non - small cell lung cancer: current treatment and future advances, translational lung cancer research. journal focusing on closing the gap between “bench and dedside”, vol:5, no:3 (June 30,2016).
22. Tepotinib: Uses, Interactions, Mechanism of Action | DrugBank Online.
Published
11/02/2025
Statistics
317 Views | 160 Downloads
Citatons
How to Cite
T, J., M, S., Yerikala, R., Y, P. C., & Venugopalaiah, P. (2025). A review on lung cancer. The Journal of Multidisciplinary Research, 5(1), 1-6. https://doi.org/10.37022/tjmdr.v5i1.652
Section
Review Articles